Video
Author(s):
Monika Fischer, MD, discusses the outcomes of a study assessing fecal microbiota transplantation for c. difficile infection at the 2014 ACG Annual Scientific Meeting in Philadelphia, PA.
Monika Fischer, MD, discusses the outcomes of fecal microbiota transplantation for c. difficile at the 2014 ACG Annual Scientific Meeting in Philadelphia, PA.
She talks about the safety and efficacy of her research findings and how that will further encourage her work.
“The overall efficacy was 88%. The conclusion from our study is that yes, fecal transplant is a highly successful procedure: however, in order to achieve a 90% or higher cure rate, we most likely need to administer 2 or more fecal transplants," said Fischer.